Yuka Asano et al. evaluated the association of pCR and TIL rate in the surgical specimens of 177 patients with stage IIA, IIB or IIIA TNBC or HER2 + breast cancer (BC) receiving neoadjuvant chemotherapy (NACT). The gene discussed is ERBB2; the disease is breast carcinoma.